{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:22:58Z","timestamp":1760548978873},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T00:00:00Z","timestamp":1276041600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0011026","type":"journal-article","created":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T21:49:16Z","timestamp":1276120156000},"page":"e11026","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Association of Carotid Plaque Lp-PLA2 with Macrophages and Chlamydia pneumoniae Infection among Patients at Risk for Stroke"],"prefix":"10.1371","volume":"5","author":[{"given":"Berna","family":"Atik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Claiborne","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2010,6,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/oxfordjournals.aje.a010233","article-title":"Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study.","volume":"151","author":"LE Chambless","year":"2000","journal-title":"Am J Epidemiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.jacc.2007.11.079","article-title":"The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.","volume":"51","author":"ER Mohler 3rd","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1006\/bbrc.1999.1066","article-title":"Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma.","volume":"261","author":"K Asano","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"16667","DOI":"10.1016\/S0021-9258(18)55353-9","article-title":"Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase.","volume":"266","author":"EB Tarbet","year":"1991","journal-title":"J Biol Chem"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/bj3380479","article-title":"Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor.","volume":"338 ( Pt 2)","author":"CH MacPhee","year":"1999","journal-title":"Biochem J"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1161\/01.ATV.0000222983.73369.c8","article-title":"Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress.","volume":"26","author":"W Koenig","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.CIR.0000116763.91992.F1","article-title":"Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.","volume":"109","author":"CM Ballantyne","year":"2004","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM200010193431603","article-title":"Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.","volume":"343","author":"CJ Packard","year":"2000","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1161\/01.ATV.19.12.2909","article-title":"Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions.","volume":"19","author":"T Hakkinen","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0163-4453(92)91913-V","article-title":"The epidemiology and significance of <italic>Chlamydia pneumoniae<\/italic>.","volume":"25","author":"P Saikku","year":"1992","journal-title":"J Infect"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1073\/pnas.92.15.6911","article-title":"<italic>Chlamydia pneumoniae<\/italic> (TWAR) in coronary arteries of young adults (15\u201334 years old).","volume":"92","author":"CC Kuo","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"S514","DOI":"10.1016\/S0002-8703(99)70289-9","article-title":"Animal models of chlamydia and atherosclerosis.","volume":"138","author":"JB Muhlestein","year":"1999","journal-title":"Am Heart J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-125-12-199612150-00008","article-title":"Isolation of <italic>Chlamydia pneumoniae<\/italic> from the coronary artery of a patient with coronary atherosclerosis. The <italic>Chlamydia pneumoniae<\/italic>\/Atherosclerosis Study Group.","volume":"125","author":"JA Ramirez","year":"1996","journal-title":"Ann Intern Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1128\/IAI.65.11.4832-4835.1997","article-title":"<italic>Chlamydia pneumoniae<\/italic> infection induces inflammatory changes in the aortas of rabbits.","volume":"65","author":"K Laitinen","year":"1997","journal-title":"Infect Immun"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/039463200902200102","article-title":"<italic>Chlamydia pneumoniae<\/italic> and atherosclerosis: current state and future prospectives.","volume":"22","author":"R Sessa","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"S402","DOI":"10.1086\/315596","article-title":"Background and current knowledge of <italic>Chlamydia pneumoniae<\/italic> and atherosclerosis.","volume":"181","author":"JT Grayston","year":"2000","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1161\/01.CIR.96.7.2144","article-title":"<italic>Chlamydia pneumoniae<\/italic>, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery.","volume":"96","author":"B Chiu","year":"1997","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1161\/01.ATV.0000189157.88630.d1","article-title":"<italic>Chlamydia pneumoniae<\/italic> burden in carotid arteries is associated with upregulation of plaque interleukin-6 and elevated C-reactive protein in serum.","volume":"25","author":"SC Johnston","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1161\/hs1201.099631","article-title":"C-reactive protein levels and viable <italic>Chlamydia pneumoniae<\/italic> in carotid artery atherosclerosis.","volume":"32","author":"SC Johnston","year":"2001","journal-title":"Stroke"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/01.CIR.102.8.833","article-title":"Infections, immunity, and atherosclerosis: associations of antibodies to <italic>Chlamydia pneumoniae<\/italic>, <italic>Helicobacter pylori<\/italic>, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis.","volume":"102","author":"M Mayr","year":"2000","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/01.STR.32.4.855","article-title":"Presence of <italic>Chlamydia pneumoniae<\/italic> in human symptomatic and asymptomatic carotid atherosclerotic plaque.","volume":"32","author":"R LaBiche","year":"2001","journal-title":"Stroke"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s100960050481","article-title":"Isolation and continuous growth of <italic>Chlamydia pneumoniae<\/italic> from arterectomy specimens.","volume":"19","author":"P Apfalter","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-125-12-199612150-00008","article-title":"Isolation of <italic>Chlamydia pneumoniae<\/italic> from the coronary artery of a patient with coronary atherosclerosis. The <italic>Chlamydia pneumoniae<\/italic>\/Atherosclerosis Study Group.","volume":"125","author":"JA Ramirez","year":"1996","journal-title":"Ann Intern Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cardiores.2005.07.011","article-title":"Delivery of <italic>Chlamydia pneumoniae<\/italic> to the vessel wall aggravates atherosclerosis in LDLr\u2212\/\u2212 mice.","volume":"69","author":"AD Hauer","year":"2006","journal-title":"Cardiovasc Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cardiores.2004.09.031","article-title":"<italic>Chlamydia pneumoniae<\/italic> infections in mouse models: relevance for atherosclerosis research.","volume":"65","author":"MD de Kruif","year":"2005","journal-title":"Cardiovasc Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/jac\/dki128","article-title":"A 6 week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with <italic>Chlamydia pneumoniae<\/italic>.","volume":"55","author":"E Blessing","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.4049\/jimmunol.180.8.5490","article-title":"Immunoproteomic identification and serological responses to novel <italic>Chlamydia pneumoniae<\/italic> antigens that are associated with persistent <italic>C. pneumoniae<\/italic> infections.","volume":"180","author":"S Bunk","year":"2008","journal-title":"J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1011972424529","article-title":"In vitro susceptibility and eradication of <italic>Chlamydia pneumoniae<\/italic> cardiovascular strains from coronary artery endothelium and smooth muscle cells.","volume":"15","author":"J Gieffers","year":"2001","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/eurheartj\/ehl565","article-title":"Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients.","volume":"28","author":"J Oldgren","year":"2007","journal-title":"Eur Heart J"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/eurheartj\/ehn502","article-title":"Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study.","volume":"30","author":"S Tsimikas","year":"2009","journal-title":"Eur Heart J"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2007.12.001","article-title":"Lp-PLA2 activity and mass are associated with increased incidence of ischemic stroke: a population-based cohort study from Malmo, Sweden.","volume":"200","author":"M Persson","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/01.ATV.0000201289.83256.cf","article-title":"Lipoprotein-associated phospholipase A2 and measures of extracoronary atherosclerosis: the Rotterdam Study.","volume":"26","author":"I Kardys","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/000331970505600413","article-title":"Lack of association between carotid intima-media thickness and PAF-acetylhydrolase mass and activity in patients with primary hyperlipidemia.","volume":"56","author":"DN Kiortsis","year":"2005","journal-title":"Angiology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2893.2006.00766.x","article-title":"Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase\/PAF system activity in patients with chronic hepatitis C virus infection.","volume":"14","author":"P Caini","year":"2007","journal-title":"J Viral Hepat"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4269\/ajtmh.1993.49.455","article-title":"Increased serum phospholipase A2 activity in Malawian children with falciparum malaria.","volume":"49","author":"P Vadas","year":"1993","journal-title":"Am J Trop Med Hyg"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1161\/01.CIR.103.18.2283","article-title":"High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection.","volume":"103","author":"BJ Van Lenten","year":"2001","journal-title":"Circulation"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/314931","article-title":"Cellular oxidation of low-density lipoprotein by <italic>Chlamydia pneumoniae<\/italic>.","volume":"180","author":"MV Kalayoglu","year":"1999","journal-title":"J Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1586\/14737159.7.5.511","article-title":"Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target.","volume":"7","author":"JF Carlquist","year":"2007","journal-title":"Expert Rev Mol Diagn"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1096\/fj.05-5514fje","article-title":"Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1beta.","volume":"20","author":"A Jaulmes","year":"2006","journal-title":"FASEB J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1379\/1466-1268(1997)002<0094:CEOIVE>2.3.CO;2","article-title":"Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins.","volume":"2","author":"A Amberger","year":"1997","journal-title":"Cell Stress Chaperones"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/01.CIR.99.24.3103","article-title":"Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators.","volume":"99","author":"TB Rajavashisth","year":"1999","journal-title":"Circulation"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1073\/pnas.85.8.2805","article-title":"Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.","volume":"85","author":"MT Quinn","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1172\/JCI115932","article-title":"Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells.","volume":"90","author":"N Kume","year":"1992","journal-title":"J Clin Invest"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1161\/01.ATV.0000069208.20268.D0","article-title":"Lysophosphatidylcholine regulates synthesis of biglycan and the proteoglycan form of macrophage colony stimulating factor.","volume":"23","author":"MY Chang","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1128\/IAI.68.6.3635-3641.2000","article-title":"Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with <italic>Chlamydia pneumoniae<\/italic>.","volume":"68","author":"J Rodel","year":"2000","journal-title":"Infect Immun"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1600-0463.2008.01145.x","article-title":"Expression of chemokines and adhesion molecules in human coronary artery endothelial cells infected with Chlamydia (<italic>Chlamydophila<\/italic>) pneumoniae.","volume":"116","author":"M H\u00f6gdahl","year":"2008","journal-title":"APMIS"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1253\/circj.70.815","article-title":"Association of <italic>Chlamydia pneumoniae<\/italic> infection and carotid intima-media wall thickness in Japanese Americans.","volume":"70","author":"K Jitsuiki","year":"2006","journal-title":"Circ J"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1532-5415.2008.01667.x","article-title":"Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: The Cardiovascular Health Study.","volume":"56","author":"CD Furberg","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/eurheartj\/ehn515","article-title":"Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.","volume":"30","author":"C Antoniades","year":"2009","journal-title":"Eur Heart J"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0011026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T05:10:21Z","timestamp":1635484221000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0011026"}},"subtitle":[],"editor":[{"given":"David M.","family":"Ojcius","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,6,9]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2010,6,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0011026","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,9]]}}}